Skip to main content
. Author manuscript; available in PMC: 2022 Oct 1.
Published in final edited form as: J Allergy Clin Immunol Pract. 2021 Jun 6;9(10):3679–3685.e1. doi: 10.1016/j.jaip.2021.05.022

Table 3:

Multivariate analysis of snoring and asthma morbidity

How often does your child snore?
No snoring
N=363
(177 subjects)
Rare snoring
N=319
(190 subjects)
Sometimes snoring
N=239
(148 subjects)
Habitual snoring
N=265
(128 subjects)
Health Outcomes
Maximum Symptom days Reference group OR=0.98
(0.75,1.27)
p=0.87
OR=1.01
(0.77, 1.33)
p=0.92
OR=1.58
(1.19,2.10)
P=0.002ab
Healthcare use Reference group IRR=1.17
(0.74,1.84)
p=0.49
IRR=1.18
(0.72,1.92)
p=0.52
IRR=1.72
(1.10,2.69)
p=0.02
School absences Reference group IRR=1.12
(0.78,1.61)
p=0.54
IRR=1.24
(0.82,1.88)
p=0.31
IRR=1.28
(0.84,1.93)
p=0.25
Missed sleep Reference group OR=1.45
(1.01,2.08)
p=0.04
OR=1.69
(1.07,2.66)
p=0.02
OR=2.35
(1.55,3.56)
p<0.001c
Changed plans Reference group OR=1.48
(0.91,2.40)
p=0.11
OR=1.47
(0.79,2.72)
p=0.22
OR=2.63
(1.50,4.62)
p=0.001de
Composite asthma control Reference group OR=1.24
(0.91,1.69)
p=0.17
OR=1.29
(0.93,1.80)
p=0.13
OR=1.49
(1.05,2.11)
p=0.03

IRR=incidence rate ratio, OR=odds ratio, p=p-value

a

significantly different than Rare snoring (OR=1.62 [1.20,2.17], p=0.001)

b

significantly different than Sometimes snoring (OR=1.56 [1.17,2.07], p=0.002)

c

significantly different than Rare snoring (OR=1.62 [1.10,2.39], p=0.02)

d

significantly different than Rare snoring (OR=1.78 [1.06,2.98], p=0.03)

e

significantly different than Sometimes snoring (OR=1.79 [1.04,3.09], p=0.04)All results adjusting for BMI category, income, nasal symptoms with a cold/flu, and nasal symptoms without a cold/flu

Primary outcome: Maximum asthma symptom days were determined by the largest value among the following three variables in the 14 days prior to each survey: (a) number of days with wheezing, chest tightness, or cough, (b) number of days on which child had to slow down or stop his/her play or activities due to wheezing, chest tightness, or cough, and (c) number of nights the participant woke up because of wheezing, chest tightness, or cough leading to disturbed sleep. The outcome is a score from 0–14 days.

Secondary outcomes: Healthcare use was defined as number of hospitalizations and unscheduled health care visits; school absences and changed plans were defined as number of days of missed school or change in caregiver plans; missed sleep was defined as number of nights caregiver lost sleep because of child’s asthma; a composite outcome of poor asthma control over the prior 4 weeks was defined by any of the following: shortness of breath more than twice weekly, nighttime awakenings owing to asthma at least once, limitation in activity level, or use of rescue asthma medication 2 or more times weekly.